OTTAWA, Nov. 9 /CNW Telbec/ - Health Canada is warning consumers not to
use certain weight loss products from China because they have been found to
contain sibutramine, a prescription medication that should only be taken under
The products in question are RS Slim & Fit, Xianting Qianzhisu, Menze
Qianweisu, Shou Shen Dan-Xiao Nan Wan, Kartien Slimming Herbs Capsules, and
Kartien Trimming Formula.
None of these products are approved for sale in Canada, and so far have
not been found on the Canadian market. While the Hong Kong Government has
recalled these products, some might still be available on the market there.
Canadians travelling to Asia are therefore warned against purchasing any of
Sibutramine is a prescribed medication used for weight loss and should
only be taken under the guidance of a health care professional. If used
improperly, it could have serious health consequences, including eye pain and
eye hemorrhage, increased heart rate and raised blood pressure. People with
heart or circulatory system problems should not take sibutramine. It should
also not be taken with antidepressants or other medications that can affect
the level of serotonin in the brain.
Consumers who are currently using any of these herbal weight loss
products should stop taking the product immediately. Current and former users
who are concerned about their health should contact their health care
professional for advice.
Canadians should only use drugs and natural health products that have
been authorized for sale by Health Canada. Authorized drugs and natural health
products will bear either an eight-digit Drug Identification Number (DIN), a
Natural Product Number (NPN) or a Homeopathic Drug Number (DIN-HM). This
authorization indicates that the products have been assessed by Health Canada
for safety, effectiveness and quality.
Members of the public are encouraged to inform Health Canada if they are
aware of the sale of any of these herbal slimming products. The toll-free
number for calls to the Health Products and Food Branch Inspectorate is
To date, no adverse reactions from the use of these products have been
reported in Canada. To report a suspected adverse reaction, please contact the
Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by
one of the following methods: